Jason Coloma, Ph.D.
Jason joined Third Rock in 2017 to focus on new company formation. His portfolio company roles include:
- Interim chief business officer of Celsius Therapeutics
- Interim chief business officer of insitro
- Interim chief operating officer of Maze Therapeutics
Jason's professional experience spans company formation and operations, corporate and business development, finance and R&D in the biotechnology industry.
Prior to joining Third Rock, Jason held a number of roles including chief business officer at Corvus Pharmaceuticals and vice president of oncology partnering and venture & innovation at Roche. At Roche, Jason led or oversaw numerous transactions ranging from research collaborations to mergers and acquisitions including partnerships with Third Rock portfolio companies Foundation Medicine and Blueprint Medicines. Before joining Roche, Jason was a consultant in the life sciences practice at L.E.K. Consulting. He also worked in finance at Amgen and in research at the University of California, San Francisco and Cytokinetics.
Jason holds a Ph.D. and M.P.H. from the University of California, Berkeley, an MBA from the Tuck School of Business at Dartmouth and a B.S. in biology from the University of San Francisco.
Although Jason has spent nearly a decade living outside the United States, he is embarrassed to admit that his language skills are limited to asking for the check and the bathroom in German, French, Italian and Japanese.